Activity and safety of brigatinib in ALK-rearranged non-small-cell lung cancer and other malignancies: a single-arm, open-label, phase 1/2 trial (Q46143489)
Jump to navigation
Jump to search
scientific article published on 7 November 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Activity and safety of brigatinib in ALK-rearranged non-small-cell lung cancer and other malignancies: a single-arm, open-label, phase 1/2 trial |
scientific article published on 7 November 2016 |
Statements
1 reference
Activity and safety of brigatinib in ALK-rearranged non-small-cell lung cancer and other malignancies: a single-arm, open-label, phase 1/2 trial (English)
1 reference
Rafael Rosell
1 reference
Ravi Salgia
1 reference
Scott N Gettinger
1 reference
Lyudmila A Bazhenova
1 reference
Corey J Langer
1 reference
Kathryn A Gold
1 reference
Alice T Shaw
1 reference
Glen J Weiss
1 reference
Meera Tugnait
1 reference
Narayana I Narasimhan
1 reference
David J Dorer
1 reference
David Kerstein
1 reference
Victor M Rivera
1 reference
Timothy Clackson
1 reference
Frank G Haluska
1 reference
David Ross Camidge
1 reference
7 November 2016
1 reference
1 reference
17
1 reference
12
1 reference
1683-1696
1 reference
Identifiers
1 reference
1 reference